🇺🇸 FDA
Patent

US 10265387

Compositions and methods for treatment of homocystinuria

granted A61KA61K2300/00A61K31/198

Quick answer

US patent 10265387 (Compositions and methods for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K2300/00, A61K31/198, A61K31/205, A61K31/385